Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Liver Cirrhosis

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 32 articles: HTML format

Single Articles

November 2021
1. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
   The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.
   Clin Res Hepatol Gastroenterol. 2021 Nov 20:101838.
   PubMed     Abstract available
   
   
   October 2021
2. ZHANG L, Zhou Y, Zhang J
   An incidental hepatic lesion in a cirrhotic liver.
   Clin Res Hepatol Gastroenterol. 2021 Oct 28:101825.
   PubMed    
   
   
   
3. MOGA L, Robic MA, Blasco-Perrin H, Cabarrou P, et al
   Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients.
   Clin Res Hepatol Gastroenterol. 2021 Oct 27:101822.
   PubMed     Abstract available
   
   
   
4. ARTZNER T, Legeai C, Antoine C, Jasseron C, et al
   Liver transplantation for critically ill cirrhotic patients: results from the French transplant registry.
   Clin Res Hepatol Gastroenterol. 2021 Oct 1:101817.
   PubMed     Abstract available
   
   
   August 2021
5. BOUZBIB C, El Mourabit H, Wendum D, Lasnier E, et al
   ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.
   Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784.
   PubMed     Abstract available
   
   
   July 2021
6. LANTHIER N, Starkel P, Dahlqvist G
   Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
   Clin Res Hepatol Gastroenterol. 2021;45:101721.
   PubMed     Abstract available
   
   
   June 2021
7. QU Y, Li T, Lin C, Liu F, et al
   Animal Naming Test for the Assessment of Minimal Hepatic Encephalopathy in Asian Cirrhotic Populations.
   Clin Res Hepatol Gastroenterol. 2021 Jun 3:101729.
   PubMed     Abstract available
   
   
   
8. RAZAQ S, Kara M, Ozcakar L
   Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
   Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.
   PubMed    
   
   
   April 2021
9. OZCELIK F
   Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
   Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.
   PubMed    
   
   
   
10. CARDOSO CC, Matiollo C, Pereira CHJ, Fonseca JS, et al
    B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2021 Apr 11:101698.
    PubMed     Abstract available
    
    
    March 2021
11. TORNAI D, Vitalis Z, Jonas A, Janka T, et al
    Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
    Clin Res Hepatol Gastroenterol. 2021;45:101579.
    PubMed     Abstract available
    
    
    
12. CAO X, Cao Z, Ou C, Zhang L, et al
    Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101583.
    PubMed     Abstract available
    
    
    
13. LANTHIER N, Starkel P, Dahlqvist G
    Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?
    Clin Res Hepatol Gastroenterol. 2021 Mar 2:101661.
    PubMed     Abstract available
    
    
    
14. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    
    
    
    February 2021
15. GAO Y, Liu H, Tang F, Zhang X, et al
    Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021 Feb 15:101649.
    PubMed     Abstract available
    
    
    November 2020
16. HUANG C, Seah JJ, Tan CK, Kam JW, et al
    Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101528.
    PubMed     Abstract available
    
    
    September 2020
17. MONTASSER IF, Ibrahim AA, Farid HM, Al Balakosy AM, et al
    De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?
    Clin Res Hepatol Gastroenterol. 2020 Sep 5. pii: S2210-7401(20)30212.
    PubMed     Abstract available
    
    
    August 2020
18. ELKRIEF L, Houssel-Debry P, Ackermann O, Franchi-Abella S, et al
    Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 Aug 17. pii: S2210-7401(20)30091.
    PubMed     Abstract available
    
    
    July 2020
19. TRIPON S, Mayer P, Svab A, Habersetzer F, et al
    Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Jul 9. pii: S2210-7401(20)30181.
    PubMed     Abstract available
    
    
    May 2020
20. HEURGUE A, Habes D, Brugel M, Franchi-Abella S, et al
    Recent (non-cirrhotic) extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 May 21. pii: S2210-7401(20)30074.
    PubMed    
    
    
    April 2020
21. ABERGEL A, Gasperment M, Nery FG, Buchard B, et al
    Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Apr 17. pii: S2210-7401(20)30089.
    PubMed    
    
    
    January 2020
22. PETA V, Zhu J, Lubman DM, Huguet S, et al
    Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Jan 18. pii: S2210-7401(19)30272.
    PubMed     Abstract available
    
    
    
23. HEDJOUDJE A, Cervoni JP, Patry C, Chatot M, et al
    Takotsubo cardiomyopathy triggered by delirium tremens in a cirrhotic patient with acute-on-chronic liver failure: A case report.
    Clin Res Hepatol Gastroenterol. 2020 Jan 9. pii: S2210-7401(19)30262.
    PubMed     Abstract available
    
    
    December 2019
24. PETIT PR, Borentain P, Aherfi S, Gerolami R, et al
    Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral blood.
    Clin Res Hepatol Gastroenterol. 2019 Dec 28. pii: S2210-7401(19)30258.
    PubMed    
    
    
    
25. ZARSKI JP, David-Tchouda S, Trocme C, Margier J, et al
    Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256.
    PubMed     Abstract available
    
    
    November 2019
26. ALLAIRE M, Cadranel JF, Nguyen TTN, Garioud A, et al
    Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Clin Res Hepatol Gastroenterol. 2019 Nov 6. pii: S2210-7401(19)30224.
    PubMed     Abstract available
    
    
    October 2019
27. ALLAIRE M, Walter A, Sutter O, Nahon P, et al
    TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Oct 26. pii: S2210-7401(19)30217.
    PubMed     Abstract available
    
    
    June 2019
28. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available
    
    
    February 2019
29. GUILLAUD O, Dumortier J, Traclet J, Restier L, et al
    Assessment of liver fibrosis by transient elastography (Fibroscan((R))) in patients with A1AT deficiency.
    Clin Res Hepatol Gastroenterol. 2019;43:77-81.
    PubMed     Abstract available
    
    
    
30. YU C, Wang L, Xue H, Lin H, et al
    Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Clin Res Hepatol Gastroenterol. 2019;43:58-66.
    PubMed     Abstract available
    
    
    
31. CASTRO NARRO GE, Consuelo Sanchez A, Salazar Martinez A, Gamboa Dominguez A, et al
    The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e4-e6.
    PubMed    
    
    
    January 2019
32. LEBRAY P, Varnous S
    Combined heart and liver transplantation: State of knowledge and outlooks.
    Clin Res Hepatol Gastroenterol. 2019 Jan 8. pii: S2210-7401(18)30173.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: